1. Home
  2. BSII vs GNFT Comparison

BSII vs GNFT Comparison

Compare BSII & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BSII
  • GNFT
  • Stock Information
  • Founded
  • BSII 2024
  • GNFT 1999
  • Country
  • BSII Hong Kong
  • GNFT France
  • Employees
  • BSII N/A
  • GNFT N/A
  • Industry
  • BSII
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BSII
  • GNFT Health Care
  • Exchange
  • BSII Nasdaq
  • GNFT Nasdaq
  • Market Cap
  • BSII 189.9M
  • GNFT 172.2M
  • IPO Year
  • BSII 2024
  • GNFT 2019
  • Fundamental
  • Price
  • BSII $9.95
  • GNFT $3.47
  • Analyst Decision
  • BSII
  • GNFT Strong Buy
  • Analyst Count
  • BSII 0
  • GNFT 1
  • Target Price
  • BSII N/A
  • GNFT $13.00
  • AVG Volume (30 Days)
  • BSII 51.0
  • GNFT 6.9K
  • Earning Date
  • BSII 01-01-0001
  • GNFT 09-19-2024
  • Dividend Yield
  • BSII N/A
  • GNFT N/A
  • EPS Growth
  • BSII N/A
  • GNFT N/A
  • EPS
  • BSII N/A
  • GNFT 0.47
  • Revenue
  • BSII N/A
  • GNFT $86,225,222.00
  • Revenue This Year
  • BSII N/A
  • GNFT $145.20
  • Revenue Next Year
  • BSII N/A
  • GNFT N/A
  • P/E Ratio
  • BSII N/A
  • GNFT $7.23
  • Revenue Growth
  • BSII N/A
  • GNFT 175.45
  • 52 Week Low
  • BSII $10.05
  • GNFT $3.33
  • 52 Week High
  • BSII $10.30
  • GNFT $6.42
  • Technical
  • Relative Strength Index (RSI)
  • BSII N/A
  • GNFT 31.89
  • Support Level
  • BSII N/A
  • GNFT $3.35
  • Resistance Level
  • BSII N/A
  • GNFT $3.57
  • Average True Range (ATR)
  • BSII 0.00
  • GNFT 0.11
  • MACD
  • BSII 0.00
  • GNFT 0.01
  • Stochastic Oscillator
  • BSII 0.00
  • GNFT 21.82

About BSII Black Spade Acquisition II Co Class A Ordinary Share

Black Spade Acquisition II Co is a blank check company.

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

Share on Social Networks: